ArticleAmerican journal of translational research2020

Combined treatment with anlotinib and chemotherapy for advanced esophageal squamous cell carcinoma improved patient survival: a case report.

Dongyang Yang et al.PubMed ↗Full text ↗

No numbers read from the abstract.